ID   SNU-899 R1
AC   CVCL_A6IV
DR   cancercelllines; CVCL_A6IV
DR   Wikidata; Q107116947
RX   CelloPub=CLPUB00626;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; 5173; HRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000035554; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5105 ! SNU-899
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
RX   CelloPub=CLPUB00626;
RA   Chon K.-M., Wang S.-G., Lee B.-J., Lee J.-C., Koo H.-J., Kim S.-H.;
RT   "Establishment of cisplatin resistant head and neck cancer cell lines
RT   and cross-resistance of docetaxel.";
RL   Korean J. Otolaryngol. 48:651-655(2005).
//